Quantitative Assessment of Drug Delivery to Tissues and Association with Phospholipidosis: A Case Study with Two Structurally Related Diamines in Development

Molecular Pharmaceutics
Irena LoryanM Hammarlund-Udenaes

Abstract

Drug induced phospholipidosis (PLD) may be observed in the preclinical phase of drug development and pose strategic questions. As lysosomes have a central role in pathogenesis of PLD, assessment of lysosomal concentrations is important for understanding the pharmacokinetic basis of PLD manifestation and forecast of potential clinical appearance. Herein we present a systematic approach to provide insight into tissue-specific PLD by evaluation of unbound intracellular and lysosomal (reflecting acidic organelles) concentrations of two structurally related diprotic amines, GRT1 and GRT2. Their intratissue distribution was assessed using brain and lung slice assays. GRT1 induced PLD both in vitro and in vivo. GRT1 showed a high intracellular accumulation that was more pronounced in the lung, but did not cause cerebral PLD due to its effective efflux at the blood-brain barrier. Compared to GRT1, GRT2 revealed higher interstitial fluid concentrations in lung and brain, but more than 30-fold lower lysosomal trapping capacity. No signs of PLD were seen with GRT2. The different profile of GRT2 relative to GRT1 is due to a structural change resulting in a reduced basicity of one amino group. Hence, by distinct chemical modifications, unde...Continue Reading

References

Dec 1, 1979·Biochemical Pharmacology·H Lüllmann, M Wehling
Jul 1, 1992·Environmental Health Perspectives·P HeilmannW G Kreyling
Jan 1, 1987·Thorax·M P Barrowcliffe, J G Jones
Aug 1, 1972·Acta Pathologica Japonica·T ShikataK Nagashima
Feb 1, 1997·Pharmacology & Toxicology·W A Daniel, J Wójcikowski
May 1, 1997·American Journal of Respiratory Cell and Molecular Biology·A JohanssonP Camner
Nov 5, 2002·Biopharmaceutics & Drug Disposition·J Cory Kalvass, Tristan S Maurer
Jun 1, 1964·The Journal of Cell Biology·E R WEIBEL, B W KNIGHT
Mar 21, 2006·Journal of Cellular Physiology·Kunihiko NagasawaNorimasa Sawada
Nov 2, 2006·The Journal of Toxicological Sciences·Kaori TomizawaIkuo Horii
Nov 7, 2006·American Journal of Physiology. Lung Cellular and Molecular Physiology·D Michael Shasby
Jun 27, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus FridénMargareta Hammarlund-Udenaes
Dec 7, 2007·Pharmaceutical Research·Margareta Hammarlund-UdenaesAnubha Gupta
Mar 21, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus FridénMargareta Hammarlund-Udenaes
Oct 17, 2009·Toxicologic Pathology·Mark E CartwrightThomas E Davis
Apr 2, 2010·Chemical Research in Toxicology·Umesh M HanumegowdaStephen P Adams
Oct 19, 2010·International Journal of Antimicrobial Agents·Jayesh DhananiJohn F Fraser
Dec 15, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Markus FridénUlf Bredberg
Dec 27, 2011·Toxicology and Applied Pharmacology·François MarceauGuillaume Morissette
Jan 23, 2013·Fluids and Barriers of the CNS·Irena LoryanMargareta Hammarlund-Udenaes
Feb 5, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Faraz KazmiAndrew Parkinson
Sep 5, 2013·Journal of Biomolecular Screening·Sampada A ShahaneMenghang Xia
Sep 18, 2014·Bioorganic & Medicinal Chemistry·Svetoslav H SlavovRichard D Beger
Dec 30, 2014·European Journal of Medicinal Chemistry·Laura GoracciSimon Cross
Jul 17, 2015·Journal of Pharmaceutical Sciences·Erica BäckströmMarkus Fridén

❮ Previous
Next ❯

Citations

Feb 19, 2019·Chemical Science·Hannah M BrittJohn M Sanderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.